News
Cathie Wood isn’t backing off Tesla; she’s buying in deeper. The Ark Invest founder just added another 115,380 Tesla shares on July 15 across two of her flagship funds. The buy totaled roughly $36 ...
Guardant is another Cathie Wood stock that stands to grow into the huge market for preventative cancer screening. The company uses proprietary blood-based tests and advanced analytics to manage ...
At least that's what Cathie Wood's recent purchases suggest. ... Medicare and other end payers are generally keen to pay $2,841 for the blood-based test because it's still cheaper than the ...
Cathie Wood makes surprising chip bet as AI battle heats up originally appeared on TheStreet. Predicting the stock market’s next twist has been an exercise in humility so far this year. Yet amid ...
Elon Musk recently shared a post in which ARK Invest CEO Cathie Wood lauds him as the 'Thomas Edison of our age,' a testament to his transformative impact on humanity.
At that time, Cathie Wood's portfolio may reap the rewards in a big way -- and if you follow her into this innovative company now, your portfolio may, too. Should you invest $1,000 in Moderna ...
Cathie Wood, the star fund manager and chief executive of ARK Invest, in a Tuesday monthly market update says that the used car market is where she is expecting possible losses after a surge in ...
Cathie Wood is having another rough year. ... Shield is a simple blood test. Guardant products completed 202,800 clinical or biopharmaceutical tests last year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results